Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Hackett

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individualsB G Harvey, N R Hackett, S Ely, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Bacteriorhodopsin mutants containing single tyrosine to phenylalanine substitutions are all active in proton translocationT Mogi, L J Stern, N R Hackett, et al.
Current Opinion in Molecular Therapeutics|March 16, 2001
Antivector and antitransgene host responses in gene therapyN R Hackett, S M Kaminsky, D Sondhi, et al.
Journal of Virology|November 13, 1999
Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vectorR Ramalingam, S Rafii, S Worgall, et al.
Blood|July 13, 2000
Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term cultureK L MacKenzie, N R Hackett, R G Crystal, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1984
Specific amino acid substitutions in bacterioopsin: Replacement of a restriction fragment in the structural gene by synthetic DNA fragments containing altered codonsK M Lo, S S Jones, N R Hackett, et al.
Human Gene Therapy|March 21, 1998
Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cellsP L Leopold, B Ferris, I Grinberg, et al.
The Journal of Biological Chemistry|July 5, 1987
Structure-function studies on bacteriorhodopsin. V. Effects of amino acid substitutions in the putative helix FN R Hackett, L J Stern, B H Chao, et al.
Human Gene Therapy|December 19, 2001
Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicityA Kianmanesh, N R Hackett, J M Lee, et al.
The Journal of Biological Chemistry|July 5, 1987
Structure-function studies on bacteriorhodopsin. I. Expression of the bacterio-opsin gene in Escherichia coliR J Dunn, N R Hackett, J M McCoy, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individualsB G Harvey, N R Hackett, S Ely, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Bacteriorhodopsin mutants containing single tyrosine to phenylalanine substitutions are all active in proton translocationT Mogi, L J Stern, N R Hackett, et al.
Current Opinion in Molecular Therapeutics|March 16, 2001
Antivector and antitransgene host responses in gene therapyN R Hackett, S M Kaminsky, D Sondhi, et al.
Journal of Virology|November 13, 1999
Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vectorR Ramalingam, S Rafii, S Worgall, et al.
Blood|July 13, 2000
Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term cultureK L MacKenzie, N R Hackett, R G Crystal, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1984
Specific amino acid substitutions in bacterioopsin: Replacement of a restriction fragment in the structural gene by synthetic DNA fragments containing altered codonsK M Lo, S S Jones, N R Hackett, et al.
Human Gene Therapy|March 21, 1998
Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cellsP L Leopold, B Ferris, I Grinberg, et al.
The Journal of Biological Chemistry|July 5, 1987
Structure-function studies on bacteriorhodopsin. V. Effects of amino acid substitutions in the putative helix FN R Hackett, L J Stern, B H Chao, et al.
Human Gene Therapy|December 19, 2001
Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicityA Kianmanesh, N R Hackett, J M Lee, et al.
The Journal of Biological Chemistry|July 5, 1987
Structure-function studies on bacteriorhodopsin. I. Expression of the bacterio-opsin gene in Escherichia coliR J Dunn, N R Hackett, J M McCoy, et al.
Pageof 6